Sign In
Buy BNGO
$1.30
+0.0400 (+3.17%)
At Close: Jun 03, 2026
Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis
04:05pm, Monday, 17'th Jun 2024
American Medical Association issues Category I CPT code for the use of optical genome mapping in genome-wide analysis related to hematological malignancies
3 Sorry Healthcare Stocks to Sell in May While You Still Can
02:01pm, Tuesday, 28'th May 2024
Healthcare stocks often hold significant potential due to the constant demand for medical advancements. However, not all companies in this sector are poised for growth.
Lab Instrument Industry Update - New Commercial Entrants
09:17am, Thursday, 23'rd May 2024
Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry h
The 3 Best Healthcare Stocks to Buy in May 2024
08:00am, Friday, 10'th May 2024
Healthcare is a basic human need that can withstand economic downturns. Indeed, this important endeavor receives a huge amount of funds in developed countries globally and the West in particular.
Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript
07:12pm, Wednesday, 08'th May 2024
Start Time: 16:30 January 1, 0000 4:27 PM ET Bionano Genomics, Inc. (NASDAQ:BNGO ) Q1 2024 Earnings Conference Call May 08, 2024, 16:30 PM ET Company Participants Erik Holmlin - President and CEO Gül
Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress
04:01pm, Wednesday, 08'th May 2024
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2024.
3 Contrarian Investments to Make Now for Massive Upside Potential
01:10pm, Thursday, 25'th Apr 2024
Many investors abandon highly promising shares with little chance of failing. The phenomenon has been exacerbated by overdone fears about elevated interest rates.
Researchers used optical genome mapping in addition to whole genome sequencing in pediatric leukemia samples and identified additional structural variants.
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
01:44pm, Thursday, 04'th Apr 2024
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 8,733,62
SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of a peer-reviewed study that compared optical genome mapping (OGM) to classical c
SAN DIEGO, March 07, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Ge
Bionano Genomics, Inc. (BNGO) Q4 2023 Earnings Call Transcript
09:54pm, Tuesday, 05'th Mar 2024
Bionano Genomics, Inc. (BNGO) Q4 2023 Earnings Call Transcript
Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024
04:01pm, Tuesday, 05'th Mar 2024
SAN DIEGO, March 05, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2023 and revenue outlook fo
Bionano to Present at TD Cowen's 44th Annual Health Care Conference
08:00am, Thursday, 29'th Feb 2024
SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano's president and chief executive officer, will present at TD Cowen's 4
Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024
08:01am, Wednesday, 28'th Feb 2024
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, March 5, 2024, at 4:30 p.m. Easter
